H. Lee Moffitt Cancer Center & Research Institute

Physician, Faculty, and Staff

Christine Laronga, MD, FACS

Christine Laronga, MD, FACS

Faculty Rank:

Associate Member

Titles:

  • Program Leader, Comprehensive Breast Program
  • Section Head, Surgical Oncology

Department/Program Affiliations:

  • Risk Assessment,Detection & Intervention  
  • Breast  

Primary Address:

H. Lee Moffitt Cancer Center &
Research Institute
12902 Magnolia Drive
Tampa, FL 33612

Office:

(813) 745-8397

USF Affiliations/College Department:

  • Medicine / Oncologic Sciences
  • Medicine / Surgery

University Academic Rank:

Associate Professor

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Christine Laronga, MD, FACS

Education & Training:

  • Surgical Oncology Fellowship, University of Texas- MD Anderson Cancer Center, 2000 - Clinical/Basic Science
  • Research Fellowship, University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway, 1994
  • Resident in General Surgery, University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway, 1997
  • M.D., University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway, 1991
  • B.A., Pennsylvania State University, 1985 - Italian
  • B.S., Pennsylvania State University, 1985 - Medicine

General Board Certification / SubSpecialty:

  • Surgery

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Christine Laronga, MD, FACS

Research Interests:

Breast cancer has been Dr. Laronga's passion and obsession for many years. Her interests cover the entire range from bench basic science research to patient care (bench to bedside and back). Dr. Laronga's research involves creating proteomic profiles for different aspects of breast diseases (race; benign vs. cancer; genetic vs. sporadic breast cancer; etc.) Patient care revolves around diagnosing and treating breast cancer in a compassionate and cutting edge manner.


Clinical Interests:

1.Continuation of protein profile generation of various components of breast cancer with the hopes of developing earlier detection models, predictors or recurrences, failed response to therapy, and therapeutic targets. 2.Adding to the biorepository with breast era, nipple discharge, ductal lavage fluid and breast tissue. 3.Creating a breast database to assist in clinical and basic science research. 4.Continue to advance breast cancer diagnostics and treatment in patient practice.

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Christine Laronga, MD, FACS

Publications:

  1. Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer. 2010 Aug. Pubmedid: 20734399.   Pubmed ID: 20734399

  2. Laronga C. The "molecular" buzz in breast cancer. Cancer Control. 2010 Jul;17(3):140-141. Pubmedid: 20664510.   Pubmed ID: 20664510

  3. Lee MC, Eatrides J, Chau A, Han G, Kiluk JV, Khakpour N, Cox CE, Carter WB, Laronga C. Consequences of Axillary Ultrasound in Patients with T2 or Greater Invasive Breast Cancers. Ann Surg Oncol. 2010 Jun. Pubmedid: 20585876.   Pubmed ID: 20585876

  4. Rollison DE, Giuliano AR, Risendal BC, Sweeney C, Boulware D, Laronga C, Baumgartner KB, Byers T, Slattery ML. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat. 2010 Jun;121(3):661-669. Pubmedid: 19888649.   Pubmed ID: 19888649

  5. Sarnaik AA, Meade T, King J, Acs G, Hoover S, Cox CE, Carter WB, Laronga C. Adenoid cystic carcinoma of the breast: a review of a single institution's experience. Breast J. 2010 Mar;16(2):208-210. Pubmedid: 20030648.   Pubmed ID: 20030648

  6. Turaga K, Acs G, Laronga C. Gene expression profiling in breast cancer. Cancer Control. 2010 Jul;17(3):177-182. Pubmedid: 20664515.   Pubmed ID: 20664515

  7. Acs G, Paragh G, Chuang S, Laronga C, Zhang P. The Presence of Micropapillary Features and Retraction Artifact in Core Needle Biopsy Material Predicts Lymph Node Metastasis in Breast Carcinoma. Am J Surg Pathol. 2009 Feb;33(2):202-210. Pubmedid: 18987549.   Pubmed ID: 18987549

  8. Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, Cox CE. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009 Dec;209(6):746-752. Pubmedid: 19959044.   Pubmed ID: 19959044

  9. Loftus LS, Laronga C. Evaluating patients with chronic pain after breast cancer surgery: the search for relief. JAMA. 2009 Nov;302(18):2034-2035. Pubmedid: 19903928.   Pubmed ID: 19903928

  10. Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients. Ann Surg Oncol. 2009 Jul;16(7):1973-1981. Pubmedid: 19408048.   Pubmed ID: 19408048

  11. Wagoner M, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009 Jan;131(1):112-121. Pubmedid: 19095574.   Pubmed ID: 19095574

  12. Kiluk J, Santillan A, Kaur P, Laronga C, Meade T, Ramos D, Cox C. Feasibility of Sentinel Lymph Node Biopsy Through an Inframammary Incision for a Nipple-Sparing Mastectomy. Ann Surg Oncol. 2008 Dec;15(12):3402-3406. Pubmedid: 18820974.   Pubmed ID: 18820974

  13. Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML. Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol. 2008 Feb;167(4):447-456. Pubmedid: 18033764. Pmcid: PMC2925515.   Pubmed ID: 18033764

  14. Laronga C, Hasson D, Hoover S, Cox J, Cantor A, Cox C, Carter W. Paget's disease in the era of sentinel lymph node biopsy. Am J Surg. 2006 Oct;192(4):481-483. Pubmedid: 16978954.   Pubmed ID: 16978954

  15. Fournier K, Schiller A, Perry RR, Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg. 2004 Jun;239(6):859-863. Pubmedid: 15166965. Pmcid: PMC1356294.   Pubmed ID: 15166965

  16. Pusztai L, Gregory B, Baggerly K, Peng B, Koomen J, Kuerer H, Esteva F, Symmans W, Wagner P, Hortobagyi G, Laronga C, Semmes O, Wright GL J, DrakeRR, Vlahou A. Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer. 2004;100(9):1814-1822. Pubmedid: 15112261.   Pubmed ID: 15112261

  17. Kiluk J, Laronga C. Commentary on "The Clinical Value of Parasternal Sentinel Lymph Node Biopsy in Breast Cancer".. In: Breast Diseases: a Year Book Quarterly. 2007 ed. St Louis, MO: Mosby Yearbook; 2007;382-383.  

  18. Laronga C, Kiluk J. Commentary on "Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary node dissection". In: Breast Diseases: a Year Book Quarterly. 2007 ed. St Louis, MO: Mosby Yearbook; 2007;170-171.  

Christine Laronga, MD, FACS

Below is a list of active grants where the faculty member is the Principal Investigator. Grants are sorted by sponsor and then sorted by start date, with the more recent grant shown first.

Joining FORCEs Against Cancer: Conference on Hereditary Breast & Ovarian Cancer

1 R13 CA139632-01A1
Sponsor: Nat Institutes of Health / NCI
Project Dates: April 1, 2010 to March 31, 2011
Earned to Date: $8,000

Physician/Faculty  Contact Form

© Copyright 1996 - 2010 H. Lee Moffitt Cancer Center & Research Institute